127 related articles for article (PubMed ID: 37598464)
21. [Pulmonary neuroendocrine tumors in the new WHO 2015 classification: Start of breaking new grounds?].
Schnabel PA; Junker K
Pathologe; 2015 May; 36(3):283-92. PubMed ID: 25956813
[TBL] [Abstract][Full Text] [Related]
22. Insulinoma-associated protein 1 is a sensitive and specific marker for lung neuroendocrine tumors in cytologic and surgical specimens.
Viswanathan K; Siddiqui MT; Borczuk AC
J Am Soc Cytopathol; 2019; 8(6):299-308. PubMed ID: 31345782
[TBL] [Abstract][Full Text] [Related]
23. A Multimodal Biomarker Predicts Dissemination of Bronchial Carcinoid.
Reuling EMBP; Naves DD; Kortman PC; Broeckaert MAM; Plaisier PW; Dickhoff C; Daniels JMA; Radonic T
Cancers (Basel); 2022 Jun; 14(13):. PubMed ID: 35805004
[TBL] [Abstract][Full Text] [Related]
24. Current diagnosis and treatment of gastrointestinal carcinoids in a series of 101 patients: the significance of serum chromogranin-A, somatostatin receptor scintigraphy and somatostatin analogues.
Nikou GC; Lygidakis NJ; Toubanakis C; Pavlatos S; Tseleni-Balafouta S; Giannatou E; Mallas E; Safioleas M
Hepatogastroenterology; 2005; 52(63):731-41. PubMed ID: 15966194
[TBL] [Abstract][Full Text] [Related]
25. Thymic neuroendocrine tumors (paraganglioma and carcinoid tumors): a comparative immunohistochemical study of 46 cases.
Weissferdt A; Kalhor N; Liu H; Rodriguez J; Fujimoto J; Tang X; Wistuba II; Moran CA
Hum Pathol; 2014 Dec; 45(12):2463-70. PubMed ID: 25294372
[TBL] [Abstract][Full Text] [Related]
26. Clinicopathological and immunohistochemical study of pulmonary neuroendocrine tumors - A single-institute experience.
Pasala UJS; Hui M; Uppin SG; Kumar NN; Bhaskar K; Paramjyothi GK
Lung India; 2021; 38(2):134-138. PubMed ID: 33687006
[TBL] [Abstract][Full Text] [Related]
27. Orthopedia homeobox protein (OTP) is a sensitive and specific marker for primary pulmonary carcinoid tumors in cytologic and surgical specimens.
Viswanathan K; Borczuk AC; Siddiqui MT
J Am Soc Cytopathol; 2019; 8(1):39-46. PubMed ID: 30929758
[TBL] [Abstract][Full Text] [Related]
28. Immunohistologic analysis of gastrointestinal and pulmonary carcinoid tumors.
Al-Khafaji B; Noffsinger AE; Miller MA; DeVoe G; Stemmermann GN; Fenoglio-Preiser C
Hum Pathol; 1998 Sep; 29(9):992-9. PubMed ID: 9744317
[TBL] [Abstract][Full Text] [Related]
29. INSM1 is a novel prognostic neuroendocrine marker for luminal B breast cancer.
Razvi H; Tsang JY; Poon IK; Chan SK; Cheung SY; Shea KH; Tse GM
Pathology; 2021 Feb; 53(2):170-178. PubMed ID: 32951906
[TBL] [Abstract][Full Text] [Related]
30. Neuroendocrine secretory protein-55 (NESP-55) expression discriminates pancreatic endocrine tumors and pheochromocytomas from gastrointestinal and pulmonary carcinoids.
Srivastava A; Padilla O; Fischer-Colbrie R; Tischler AS; Dayal Y
Am J Surg Pathol; 2004 Oct; 28(10):1371-8. PubMed ID: 15371954
[TBL] [Abstract][Full Text] [Related]
31. Expression of novel neuroendocrine marker insulinoma-associated protein 1 (INSM1) in genitourinary high-grade neuroendocrine carcinomas: An immunohistochemical study with specificity analysis and comparison to chromogranin, synaptophysin, and CD56.
Chen JF; Yang C; Sun Y; Cao D
Pathol Res Pract; 2020 Jun; 216(6):152993. PubMed ID: 32381384
[TBL] [Abstract][Full Text] [Related]
32. Insulinoma-associated protein 1 is a sensitive and specific marker of neuroendocrine lung neoplasms in cytology specimens.
Doxtader EE; Mukhopadhyay S
Cancer Cytopathol; 2018 Apr; 126(4):243-252. PubMed ID: 29360191
[TBL] [Abstract][Full Text] [Related]
33. Differential Orthopedia Homeobox expression in pulmonary carcinoids is associated with changes in DNA methylation.
Moonen L; Mangiante L; Leunissen DJG; Lap LMV; Gabriel A; Hillen LM; Roemen GM; Koch A; van Engeland M; Dingemans AC; Foll M; Alcala N; Fernandez-Cuesta L; Derks JL; Speel EM
Int J Cancer; 2022 Jun; 150(12):1987-1997. PubMed ID: 35076935
[TBL] [Abstract][Full Text] [Related]
34. Typical and atypical pulmonary carcinoid tumor overdiagnosed as small-cell carcinoma on biopsy specimens: a major pitfall in the management of lung cancer patients.
Pelosi G; Rodriguez J; Viale G; Rosai J
Am J Surg Pathol; 2005 Feb; 29(2):179-87. PubMed ID: 15644774
[TBL] [Abstract][Full Text] [Related]
35. Multifocal peripheral bronchial carcinoid tumour.
Akashiba T; Matsumoto K; Kosaka N; Saito O; Horie T; Nemoto N
Respirology; 1999 Jun; 4(2):199-201. PubMed ID: 10382240
[TBL] [Abstract][Full Text] [Related]
36. Diagnostic Utility of Orthopedia Homeobox (OTP) in Pulmonary Carcinoid Tumors.
Nonaka D; Papaxoinis G; Mansoor W
Am J Surg Pathol; 2016 Jun; 40(6):738-44. PubMed ID: 26927888
[TBL] [Abstract][Full Text] [Related]
37. Immunohistochemical identification of neuron-specific enolase, synaptophysin, chromogranin and endocrine granule constituent in neuroendocrine tumours.
Vyberg M; Horn T; Francis D; Askaa J
Acta Histochem Suppl; 1990; 38():179-81. PubMed ID: 1964227
[TBL] [Abstract][Full Text] [Related]
38. Nuclear Insulinoma-Associated Protein 1 Expression as a Marker of Neuroendocrine Differentiation in Neoplasms of the Breast.
Seijnhaeve E; Galant C; Van Bockstal MR
Int J Surg Pathol; 2021 Aug; 29(5):496-502. PubMed ID: 33426999
[TBL] [Abstract][Full Text] [Related]
39. The expression of selected neuroendocrine markers and of anti-neoplastic cytokines (IL-2 and IL-12) in lung cancers.
Kasprzak A; Przewoźna M; Surdyk-Zasada J; Zabel M
Folia Morphol (Warsz); 2003 Nov; 62(4):497-9. PubMed ID: 14655151
[TBL] [Abstract][Full Text] [Related]
40. Immunohistochemical demonstration of chromogranins A and B in neuroendocrine tumors of the lung.
Tötsch M; Müller LC; Hittmair A; Ofner D; Gibbs AR; Schmid KW
Hum Pathol; 1992 Mar; 23(3):312-6. PubMed ID: 1313391
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
